Thromboembolism in multiple myeloma patients receiving thalidomide combination chemotherapy.

被引：0
|
作者：
Wrigh, A. [1 ]
Elkins, S. [1 ]
Files, J. [1 ]
Bigelow, C. [1 ]
Herrin, V. [1 ]
Sample, M. [1 ]
机构：
[1] Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2007年 / 55卷 / 01期
关键词：
D O I：
10.1097/00042871-200701010-00839
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S302 / S302
页数：1
相关论文
共 50 条
  • [21] Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide
    Youngil Koh
    Soo-Mee Bang
    Jae Hoon Lee
    Hwi-Joong Yoon
    Young-Rok Do
    Hun-Mo Ryoo
    Nari Lee
    Seok Jin Kim
    Kihyun Kim
    Sung-Soo Yoon
    Jong-Ho Won
    Yeung-Chul Mun
    Moon-Hee Lee
    Ki-Hyun Rhee
    Hyo-Jung Kim
    HyeonSeok Eom
    Min Kyoung Kim
    Hyun Chun Shin
    Annals of Hematology, 2010, 89 : 201 - 206
  • [22] The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma
    Li, Ang
    Wu, Qian
    Warnick, Greg
    Li, Shan
    Libby, Edward N.
    Garcia, David A.
    Lyman, Gary H.
    ANNALS OF HEMATOLOGY, 2020, 99 (01) : 121 - 126
  • [23] The incidence of thromboembolism for lenalidomide versus thalidomide in older patients with newly diagnosed multiple myeloma
    Ang Li
    Qian Wu
    Greg Warnick
    Shan Li
    Edward N. Libby
    David A. Garcia
    Gary H. Lyman
    Annals of Hematology, 2020, 99 : 121 - 126
  • [24] The Incidence of Thromboembolism for Lenalidomide Versus Thalidomide in Older Patients with Newly Diagnosed Multiple Myeloma
    Li, Ang
    Wu, Qian V.
    Warnick, Greg
    Libby, Edward N., III
    Garcia, David A.
    Lyman, Gary H.
    BLOOD, 2018, 132
  • [25] Incidence and prediction of venous thromboembolism (VTE) in ambulatory patients (pts) with pancreas cancer receiving chemotherapy.
    Blanco, Ana Belen Ruperez
    Martin, Andres Jesus Munoz
    Alfonso, Pilar Garcia
    Suarez, Sonsoles Alvarez
    Podesta, Mercedes Cavanagh
    Cabello, Sara Custodio
    Solis, Rebeca Mondejar
    Ataz, Daniel Lopez-Trabada
    Blanco-Codesido, Montserrat
    Martin, Miguel
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [26] HEMOSTASIS IN PATIENTS WITH MULTIPLE MYELOMA BEFORE AND DURING HIGH-DOSE CHEMOTHERAPY.
    Urnova, E.
    Pokrovskaya, O.
    Mendeleeva, L.
    Gracheva, M.
    Balandina, A.
    Vasiliev, S.
    Ataullakhanov, F.
    Savchenko, V.
    HAEMATOLOGICA, 2013, 98 : 612 - 612
  • [27] Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy
    Moehler, TM
    Neben, K
    Benner, A
    Egerer, G
    Krasniqi, F
    Ho, AD
    Goldschmidt, H
    BLOOD, 2001, 98 (13) : 3846 - 3848
  • [28] Response to a combination therapy of thalidomide and Pegintron® in patients with progressive multiple myeloma (MM).
    Kasper, B
    Moehler, TM
    Neben, K
    Ho, AD
    Goldschmidt, H
    BLOOD, 2001, 98 (11) : 309B - 309B
  • [29] Thalidomide and thrombosis in patients with multiple myeloma
    Camba, L
    Peccatori, J
    Pescarollo, A
    Tresoldi, M
    Corradini, P
    Bregni, M
    HAEMATOLOGICA, 2001, 86 (10) : 1108 - 1109
  • [30] Thalidomide and dexamethasone combination for refractory multiple myeloma.
    Galani, E
    Grigoraki, V
    Kiamouris, C
    Samantas, E
    Economou, O
    Papdimitriou, C
    Gika, D
    Anagnostopoulos, N
    Dimopoulos, M
    ANNALS OF ONCOLOGY, 2000, 11 : 96 - 96
12345